Kapitelklicken springt direkt hin
Shownotes
In this Business Breakdown, David Barbato and Sergio Heiber sit down with NeurAxis’s (NRXS) CEO Brian Carrico. The company was originally profiled by Sergio Heiber on August 18, 2024, at $3.14 USD per share.
This discussion took place live on February 18th, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions -microcapclub.com/join-now (youtube.com/redirect?event=video_description&a…)
In this conversation, Brian Carrico, CEO of Neuroaxis, discusses the company's growth, the significance of the Category One CPT code, and the current market position. He highlights the importance of strong data for insurance coverage and reimbursement, the focus on pediatric healthcare, and the expansion into the VA market. The discussion also covers the company's treatment mechanisms, ongoing clinical trials, and strategies for scaling operations. Audience questions provide further insights into insurance negotiations and market opportunities.
✉️ Share your feedback - david@microcapclub.com
✉️ David’s X (Twitter) -x.com/Valuehunte (youtube.com/redirect?event=video_description&a…)
Chapters
Introduction to Neuroxys and Brian Carrico's Background
Understanding Neuromodulation and Its Applications
Market Potential and Addressable Market
Research and Development: Clinical Trials and Data
Go-to-Market Strategy and Scaling Challenges
Financial Overview and Future Projections
Insurance Coverage and Market Expansion
Veterans Affairs Market and Initial Feedback
Focus on Pediatric Market and Future Directions
Understanding the VA Hospital System
Reimbursement and Relative Value Units (RVUs)
Capital Needs and Financial Strategy
Market Opportunities and Misconceptions
Insurance Assessment Timing and Coverage
Regulatory Considerations and FDA Interactions
Patient Treatment Protocols and Data Availability
Manufacturing and Scaling Challenges
Centers of Excellence and Patient Care
Insurance Coverage and Market Dynamics
Key Performance Indicators and Future Planning
Disclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.
